Qbrelis Prices, Coupons and Patient Assistance Programs
Qbrelis (lisinopril) is a member of the Angiotensin Converting Enzyme Inhibitors drug class and is commonly used for Heart Attack, Heart Failure, and High Blood Pressure.
Qbrelis Prices
The cost for Qbrelis oral solution (1 mg/mL) is around $578 for a supply of 150 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Qbrelis is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Qbrelis availability.
This Qbrelis price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Solution
Quantity | Per unit | Price |
---|---|---|
150 milliliters | $3.85 | $578.12 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Qbrelis Coupons and Rebates
Qbrelis offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Qbrelis eVoucherRx Program: Eligible commercially insured patients may pay no more than $30 per prescription with savings of up to $230 per fill at a participating pharmacy; for additional information contact the program at 844-472-2032.
- Applies to:
- Qbrelis
- Number of uses:
- Per prescription until program expires
Form more information phone: 844-472-2032 or Visit website
Patient Assistance Programs for Qbrelis
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Qbrelis (lisinopril) Oral Solution
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Qbrelis (lisinopril) Oral Solution
More information please phone: 866-316-7263 Visit Website
Provider: Azurity Solutions (Qbrelis)
Elligibility requirements:- Determined case by case
- Based on FPL
- Medically Necessary as determined by a Doctor
- Must be treated by US licensed healthcare provider
- Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Qbrelis (lisinopril) Oral Solution
More information please phone: 844-472-2032 Visit Website
More about Qbrelis (lisinopril)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- En español
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA approval history